1-1 of 1
Ruth Lamar, MD
Close
Sort by
Journal Articles

Phase I/II Study of Panobinostat and Carfilzomib in Patients (pts) with Relapsed or Refractory Multiple Myeloma (MM), Interim Phase I Safety Analysis

Jesus G. Berdeja, MD, Lowell Hart, MD, Ruth Lamar, MD, Patrick Murphy, MD, Susan Morgan, Ian W. Flinn, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4048.
https://doi.org/10.1182/blood.V120.21.4048.4048
Published: 2012